Aurora Cannabis (TSX:ACB) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.18) by 61.11 percent. This is a 73.08 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $67.554 million which beat the analyst consensus estimate of $65.235 million by 3.55 percent. This is a 31.08 percent decrease over sales of $98.023 million the same period last year.